Corneal Graft Surgery Combined with Subconjunctival Bevacizumab (Avastin)
Authors:
- Thomas R G PooleTPThomas R G Poole
- 1 June 2010
- journal article
- case report
- Published by Wolters Kluwer Health in Cornea
- Vol. 29 (6) , 691-693
Abstract
To describe the use of subconjunctival bevacizumab (Avastin) as an adjunctive treatment in a vascularized cornea at the time of lamellar keratoplasty to reduce the risk of graft rejection. After a significant ocular high-velocity thermal injury, a patient developed extensive corneal scarring and a traumatic cataract. To improve vision, a corneal graft was indicated, but the presence of extensive neovascularization increased the risk of early graft rejection. Bevacizumab was injected subconjunctivally before surgery to reduce the corneal vessel load. There was a dramatic response in terms of vessel regression, but this was short lived and the vessels quickly regrew. The subconjunctival bevacizumab injection was repeated at the time of combined cataract extraction and lamellar corneal graft surgery, and the feeder vessels were cauterized at the limbus. After 6 months, the graft remained clear of vessels. This case is of interest because the eye was treated twice with subconjunctival bevacizumab with good short-term results in both instances but different longer-term outcomes in terms of vessel regrowth. This case suggests that the antiangiogenic effects of bevacizumab may be effectively harnessed at the time of a definitive surgical procedure, which reduces the stimulus for vessel regrowth.Keywords
This publication has 22 references indexed in Scilit:
- Bevacizumab (Avastin) and Argon Laser to Treat Neovascularization in Corneal Transplant SurgeryCornea, 2008
- Combined Use of Superficial Keratectomy and Subconjunctival Bevacizumab Injection for Corneal NeovascularizationCornea, 2008
- Effect of Subconjunctival Bevacizumab (Avastin) on Experimental Corneal Neovascularization in Guinea PigsCornea, 2008
- Subconjunctival Bevacizumab Injection for Corneal Neovascularization in Recurrent PterygiumCurrent Eye Research, 2008
- Topical Bevacizumab and Ocular Surface Neovascularization in Patients With Stevens-Johnson SyndromeCornea, 2008
- Characteristics and Outcomes of Adult Patients Lost to Follow-Up at an Antiretroviral Treatment Clinic in Johannesburg, South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burnActa Ophthalmologica, 2007
- Bevacizumab for Graft RejectionOphthalmology, 2007
- Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesisClinical & Experimental Ophthalmology, 2007
- Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)British Journal of Ophthalmology, 2006